- The grant covers research into the two main therapeutic technologies of Brain+, digitalized Cognitive Stimulation Therapy (CST), and Computerized Cognitive Training (CCT).
- The grant will also examine the hypothesized synergy effects of combining CST with CCT, which is a key research step for the third Brain+ product in the pipeline, `CST-for-MCI'.
University of Gothenburg is hosting the grant, which has a budget of €48,405, and is funded by the EU Joint Programme -Neurodegenerative Disease Research .
The EU Joint Programme -
The grant workgroup and purpose
The workgroup is highly multi-disciplinary consisting of experimental psychologists, cognitive scientists, neuroscientists, digital solutions companies, occupational therapists, and engineers, the majority of whom have experience or expertise in working with people with dementia and caregivers. The full 16-person working group includes experts from
Contact Information
CEO and Co-founder:
Mission of Brain+
The mission of Brain+ is to make effective treatments for cognitive decline in Alzheimer's accessible to everyone as digital therapeutics
Supplementary information
Details on the grant work groups and purpose
The first group will research Cognitive training and in particular how to exploit a unique memory and attention-focused training methodology for in early stages of dementia. This methodology is the same that Brain+ is developing in another EU-grant funded project with the
The second group will research the Digitization of Cognitive Training and Psychosocial Therapy. This sub-group aims to evaluate how best to utilize multiple technologies for digitized cognitive training and psychosocial therapy. Combining different technologies as part of an intervention program is considered also to improve adherence (motivation) and permit a greater transfer of training effects to real-world relevant problems. Brain+ intends to combine its two main therapeutic methods, Cognitive Stimulation Therapy and Computerized Cognitive Training in its pipeline product for MCI, and this research will move this work forward.
The third group will researchhow best to integrate digitized psychosocial and cognitive training into a single digital platform for intervention. This is the more practical implementation research work related to combining Cognitive Stimulation Therapy and Computerized Cognitive Training effectively on one platform. This is thus the initial steps that will lead to the creation of the CST-for-MCI product for Brain+.
Composition of the JPDN-grant working group
Coordinator:
- Dr (Assoc. Prof)
Robert Lowe ,Department of Applied IT , Forskningsgången 6, 41756 GöteborgUniversity of Gothenburg , andResearch Institutes of Sweden (RISE) Email: robert.lowe@gu.se
Participants:
- Dr. (Assoc. Professor) Qarin Lood,
University of Gothenburg, Sweden - Dr. (
Senior Assoc . Professor)Rikke Gregersen ,Via College ,Denmark - Dr. Emilia Barakova,Eindhoven
University of Technology - Dr.
Pierre Gander ,University of Gothenburg, Sweden - Dr.
Simon Nielsen : Brain+,Denmark - Ph.D.,
Mia Yuan Dong , Brain+ - Ph.D.
Imy Khan , Univ ofGothenburg - PostDoc,
Nahid Zokai , Brain+,University of Oxford - Prof.
Ana B.Vivas ,University of York Europe Campus ,Greece - Prof.
Bernhard Hommel ,University of Dresden ,Germany - Prof.
Engin Erzin ,University of Koc ,Turkey - Prof.
Luis Fuentes Melero ,University of Murcia, Spain - Prof.
Maria Angeles Estevez ,University of Almeria ,Spain - Prof.
Maria Dolores Roldan Tapia ,University of Almeria ,Spain - Prof. Synneve Dahlin-Ivanoff,
University of Gothenburg, Sweden - Mr.
Jacob Michelsen :RISE AB ,Sweden
About the Brain+ product pipeline
The Company has three product programs; 1) CST*-Therapist Companion, for people with mild-to-moderate dementia, 2) CST-Home Care, for people with mild-to-moderate dementia, and 3) CST-for-MCI, for people with mild cognitive impairment.
*Cognitive Stimulation Therapy (CST)
Program 1: The first is the recently launched CST - Therapist Companion, aiming to help therapists deliver CST group sessions in clinics. This product family includes an add-on product, CST-Home Companion, that allows people in CST group sessions to practice at home in-between sessions. A 2nd version of the CST-Therapist Companion product is already in development (expected Class 1 MDR). This product only relies on the CST-technology.
Program 2: The second, is the CST Home Care product (expected Class 1/2a MDR). This product allows people who have been through a CST group session to do CST in the comfort of their own homes and to maintain benefits from CST group sessions. This product only relies on the CST-technology.
Program 3: The third, is CST-for-MCI aiming to delay the cognitive decline in people with Mild Cognitive Impairment (MCI) (expected Class 2a MDR)), each within a different regulatory class. The CST-for MCI product will combine the three Brain+ core technologies (1. CST, 2. CCT, and 3. the Starry Night cognitive test) into one product.
https://news.cision.com/brain--a-s/r/respected-dementia-experts-and-brain--gets-eu-grant-to-research-how-to-optimize-digital-at-home-trea,c3733465
https://mb.cision.com/Public/20893/3733465/bb6a9cb89f951755.pdf
https://news.cision.com/brain--a-s/i/1-b-en-rgb,c3155179
(c) 2023 Cision. All rights reserved., source